Anixa Biosciences
ANIX
$2.94
Share price
-1.01%
Change (1 day)
-26.32%
Change (1 year)
Categories
P/S ratio for Anixa Biosciences (ANIX)
P/S ratio as of May 2024 (TTM): 451
According to Anixa Biosciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 451.154. At the end of 2024 the company had a P/S ratio of 694.
P/S ratio history for Anixa Biosciences from 2009 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 694 | 54.38% |
| 2023 | 450 | |
| 2022 | N/A | -100% |
| 2021 | 278 | |
| 2020 | N/A | -100% |
| 2019 | 315 | 357.23% |
| 2018 | 68.8 | -26.69% |
| 2017 | 93.9 | -49.32% |
| 2016 | 185 | 5185.09% |
| 2015 | 3.51 | -70.74% |
| 2014 | 12.0 | -88.65% |
| 2013 | 106 | 108.61% |
| 2012 | 50.6 | 80.08% |
| 2011 | 28.1 | -37.12% |
| 2010 | 44.7 | -44.38% |
| 2009 | 80.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |